However, several factors confound the role of inflammation in generation and perpetuation of AF. As an example, failure to show a correlation between baseline hsCRP levels and maintenance of sinus ...

May 2, 2003 - A retrospective study and results of a phase 3 trial point to new approaches to both short-term cardioversion and long-term maintenance of patients with atrial fibrillation (AF).

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

The oral anticoagulant rivaroxaban is a safe and effective alternative to vitamin K antagonists for patients with atrial fibrillation (AF) undergoing cardioversion. This finding from the X-VeRT trial ...

BARCELONA, Spain—Apixaban appears to be an effective and safe alternative to heparin plus a vitamin K antagonist (VKA) for patients with A-fib who are undergoing rapid cardioversion and require ...